nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Salbutamol—chronic obstructive pulmonary disease	0.482	1	CrCtD
Phenylephrine—CYP1A2—chronic obstructive pulmonary disease	0.172	1	CbGaD
Phenylephrine—Terbutaline—Salbutamol—chronic obstructive pulmonary disease	0.0632	0.224	CrCrCtD
Phenylephrine—Norepinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0546	0.194	CrCrCtD
Phenylephrine—Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.0443	0.158	CrCrCtD
Phenylephrine—Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.0443	0.158	CrCrCtD
Phenylephrine—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0413	0.147	CrCrCtD
Phenylephrine—Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.0336	0.119	CrCrCtD
Phenylephrine—Orciprenaline—ADRB2—chronic obstructive pulmonary disease	0.000495	0.24	CrCbGaD
Phenylephrine—Terbutaline—ADRB2—chronic obstructive pulmonary disease	0.000325	0.158	CrCbGaD
Phenylephrine—Intraocular pressure increased—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00644	CcSEcCtD
Phenylephrine—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000317	0.00643	CcSEcCtD
Phenylephrine—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000317	0.00642	CcSEcCtD
Phenylephrine—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00627	CcSEcCtD
Phenylephrine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.000308	0.00624	CcSEcCtD
Phenylephrine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.0003	0.00608	CcSEcCtD
Phenylephrine—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.0003	0.00607	CcSEcCtD
Phenylephrine—Pulmonary oedema—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00605	CcSEcCtD
Phenylephrine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000297	0.00602	CcSEcCtD
Phenylephrine—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.000297	0.00601	CcSEcCtD
Phenylephrine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000287	0.00581	CcSEcCtD
Phenylephrine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00027	0.00548	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000259	0.00524	CcSEcCtD
Phenylephrine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000245	0.00496	CcSEcCtD
Phenylephrine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000242	0.00491	CcSEcCtD
Phenylephrine—Salbutamol—ADRB2—chronic obstructive pulmonary disease	0.000242	0.117	CrCbGaD
Phenylephrine—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.00489	CcSEcCtD
Phenylephrine—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00481	CcSEcCtD
Phenylephrine—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.00456	CcSEcCtD
Phenylephrine—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.0045	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000216	0.00437	CcSEcCtD
Phenylephrine—Tapentadol—SLC6A4—chronic obstructive pulmonary disease	0.000215	0.105	CrCbGaD
Phenylephrine—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.00432	CcSEcCtD
Phenylephrine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00424	CcSEcCtD
Phenylephrine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00415	CcSEcCtD
Phenylephrine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.00406	CcSEcCtD
Phenylephrine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.00406	CcSEcCtD
Phenylephrine—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00404	CcSEcCtD
Phenylephrine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00404	CcSEcCtD
Phenylephrine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000198	0.00402	CcSEcCtD
Phenylephrine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.00401	CcSEcCtD
Phenylephrine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.004	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00397	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00397	CcSEcCtD
Phenylephrine—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00395	CcSEcCtD
Phenylephrine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00395	CcSEcCtD
Phenylephrine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00392	CcSEcCtD
Phenylephrine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000191	0.00387	CcSEcCtD
Phenylephrine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.0038	CcSEcCtD
Phenylephrine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000184	0.00373	CcSEcCtD
Phenylephrine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.00367	CcSEcCtD
Phenylephrine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00018	0.00365	CcSEcCtD
Phenylephrine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000173	0.0035	CcSEcCtD
Phenylephrine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00348	CcSEcCtD
Phenylephrine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00348	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00347	CcSEcCtD
Phenylephrine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00017	0.00344	CcSEcCtD
Phenylephrine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.00343	CcSEcCtD
Phenylephrine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.00337	CcSEcCtD
Phenylephrine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00335	CcSEcCtD
Phenylephrine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00335	CcSEcCtD
Phenylephrine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000165	0.00335	CcSEcCtD
Phenylephrine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000164	0.00332	CcSEcCtD
Phenylephrine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.00332	CcSEcCtD
Phenylephrine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00331	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000163	0.0033	CcSEcCtD
Phenylephrine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00329	CcSEcCtD
Phenylephrine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00329	CcSEcCtD
Phenylephrine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00326	CcSEcCtD
Phenylephrine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00326	CcSEcCtD
Phenylephrine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00326	CcSEcCtD
Phenylephrine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00326	CcSEcCtD
Phenylephrine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00323	CcSEcCtD
Phenylephrine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00323	CcSEcCtD
Phenylephrine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000159	0.00322	CcSEcCtD
Phenylephrine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000158	0.0032	CcSEcCtD
Phenylephrine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00319	CcSEcCtD
Phenylephrine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000157	0.00319	CcSEcCtD
Phenylephrine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000157	0.00319	CcSEcCtD
Phenylephrine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000156	0.00317	CcSEcCtD
Phenylephrine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00317	CcSEcCtD
Phenylephrine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00317	CcSEcCtD
Phenylephrine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00317	CcSEcCtD
Phenylephrine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00313	CcSEcCtD
Phenylephrine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.00312	CcSEcCtD
Phenylephrine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.0031	CcSEcCtD
Phenylephrine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000153	0.0031	CcSEcCtD
Phenylephrine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.0031	CcSEcCtD
Phenylephrine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00309	CcSEcCtD
Phenylephrine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00309	CcSEcCtD
Phenylephrine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00309	CcSEcCtD
Phenylephrine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00308	CcSEcCtD
Phenylephrine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00308	CcSEcCtD
Phenylephrine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00308	CcSEcCtD
Phenylephrine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00308	CcSEcCtD
Phenylephrine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00306	CcSEcCtD
Phenylephrine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00306	CcSEcCtD
Phenylephrine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00305	CcSEcCtD
Phenylephrine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000148	0.003	CcSEcCtD
Phenylephrine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00299	CcSEcCtD
Phenylephrine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00299	CcSEcCtD
Phenylephrine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00295	CcSEcCtD
Phenylephrine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00295	CcSEcCtD
Phenylephrine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00291	CcSEcCtD
Phenylephrine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00291	CcSEcCtD
Phenylephrine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00289	CcSEcCtD
Phenylephrine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00289	CcSEcCtD
Phenylephrine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00289	CcSEcCtD
Phenylephrine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00288	CcSEcCtD
Phenylephrine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00286	CcSEcCtD
Phenylephrine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00283	CcSEcCtD
Phenylephrine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00278	CcSEcCtD
Phenylephrine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00278	CcSEcCtD
Phenylephrine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00278	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000136	0.00275	CcSEcCtD
Phenylephrine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00273	CcSEcCtD
Phenylephrine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00272	CcSEcCtD
Phenylephrine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00272	CcSEcCtD
Phenylephrine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00272	CcSEcCtD
Phenylephrine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000133	0.0027	CcSEcCtD
Phenylephrine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.00268	CcSEcCtD
Phenylephrine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00268	CcSEcCtD
Phenylephrine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00268	CcSEcCtD
Phenylephrine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00266	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00266	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00266	CcSEcCtD
Phenylephrine—Isoprenaline—ADRB2—chronic obstructive pulmonary disease	0.00013	0.0631	CrCbGaD
Phenylephrine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00262	CcSEcCtD
Phenylephrine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00261	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00261	CcSEcCtD
Phenylephrine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00256	CcSEcCtD
Phenylephrine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00253	CcSEcCtD
Phenylephrine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00253	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00252	CcSEcCtD
Phenylephrine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00252	CcSEcCtD
Phenylephrine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00252	CcSEcCtD
Phenylephrine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00251	CcSEcCtD
Phenylephrine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00251	CcSEcCtD
Phenylephrine—Epinephrine—TNF—chronic obstructive pulmonary disease	0.000123	0.0598	CrCbGaD
Phenylephrine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00249	CcSEcCtD
Phenylephrine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00249	CcSEcCtD
Phenylephrine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000123	0.00249	CcSEcCtD
Phenylephrine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000122	0.00247	CcSEcCtD
Phenylephrine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00244	CcSEcCtD
Phenylephrine—Norepinephrine—ADRB2—chronic obstructive pulmonary disease	0.00012	0.0584	CrCbGaD
Phenylephrine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.00239	CcSEcCtD
Phenylephrine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.00239	CcSEcCtD
Phenylephrine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00238	CcSEcCtD
Phenylephrine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00238	CcSEcCtD
Phenylephrine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00237	CcSEcCtD
Phenylephrine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00235	CcSEcCtD
Phenylephrine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.00234	CcSEcCtD
Phenylephrine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00234	CcSEcCtD
Phenylephrine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00229	CcSEcCtD
Phenylephrine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00229	CcSEcCtD
Phenylephrine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00226	CcSEcCtD
Phenylephrine—Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.0541	CrCbGaD
Phenylephrine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.00225	CcSEcCtD
Phenylephrine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00011	0.00223	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000109	0.00222	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.00222	CcSEcCtD
Phenylephrine—Epinephrine—ADRB2—chronic obstructive pulmonary disease	0.000109	0.053	CrCbGaD
Phenylephrine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.0022	CcSEcCtD
Phenylephrine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000108	0.0022	CcSEcCtD
Phenylephrine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00218	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000107	0.00217	CcSEcCtD
Phenylephrine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00216	CcSEcCtD
Phenylephrine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000106	0.00215	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00215	CcSEcCtD
Phenylephrine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000106	0.00214	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00214	CcSEcCtD
Phenylephrine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000105	0.00213	CcSEcCtD
Phenylephrine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000105	0.00213	CcSEcCtD
Phenylephrine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000104	0.00211	CcSEcCtD
Phenylephrine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000104	0.0021	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00209	CcSEcCtD
Phenylephrine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.00207	CcSEcCtD
Phenylephrine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00204	CcSEcCtD
Phenylephrine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00204	CcSEcCtD
Phenylephrine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.98e-05	0.00202	CcSEcCtD
Phenylephrine—Norepinephrine—CYP1A2—chronic obstructive pulmonary disease	9.95e-05	0.0483	CrCbGaD
Phenylephrine—Rash—Tiotropium—chronic obstructive pulmonary disease	9.9e-05	0.00201	CcSEcCtD
Phenylephrine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.89e-05	0.002	CcSEcCtD
Phenylephrine—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.89e-05	0.002	CcSEcCtD
Phenylephrine—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.86e-05	0.002	CcSEcCtD
Phenylephrine—Headache—Tiotropium—chronic obstructive pulmonary disease	9.84e-05	0.00199	CcSEcCtD
Phenylephrine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.83e-05	0.00199	CcSEcCtD
Phenylephrine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.5e-05	0.00193	CcSEcCtD
Phenylephrine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.34e-05	0.00189	CcSEcCtD
Phenylephrine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.34e-05	0.00189	CcSEcCtD
Phenylephrine—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.33e-05	0.00189	CcSEcCtD
Phenylephrine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.00189	CcSEcCtD
Phenylephrine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	9.14e-05	0.00185	CcSEcCtD
Phenylephrine—Epinephrine—CYP1A2—chronic obstructive pulmonary disease	9.02e-05	0.0438	CrCbGaD
Phenylephrine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.96e-05	0.00182	CcSEcCtD
Phenylephrine—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.96e-05	0.00182	CcSEcCtD
Phenylephrine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.81e-05	0.00179	CcSEcCtD
Phenylephrine—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.78e-05	0.00178	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.63e-05	0.00175	CcSEcCtD
Phenylephrine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.00173	CcSEcCtD
Phenylephrine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.46e-05	0.00172	CcSEcCtD
Phenylephrine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.38e-05	0.0017	CcSEcCtD
Phenylephrine—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.38e-05	0.0017	CcSEcCtD
Phenylephrine—Dizziness—Montelukast—chronic obstructive pulmonary disease	8.21e-05	0.00166	CcSEcCtD
Phenylephrine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.06e-05	0.00163	CcSEcCtD
Phenylephrine—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.06e-05	0.00163	CcSEcCtD
Phenylephrine—Rash—Formoterol—chronic obstructive pulmonary disease	7.99e-05	0.00162	CcSEcCtD
Phenylephrine—Rash—Arformoterol—chronic obstructive pulmonary disease	7.99e-05	0.00162	CcSEcCtD
Phenylephrine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.98e-05	0.00162	CcSEcCtD
Phenylephrine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.98e-05	0.00162	CcSEcCtD
Phenylephrine—Headache—Arformoterol—chronic obstructive pulmonary disease	7.94e-05	0.00161	CcSEcCtD
Phenylephrine—Headache—Formoterol—chronic obstructive pulmonary disease	7.94e-05	0.00161	CcSEcCtD
Phenylephrine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.92e-05	0.00161	CcSEcCtD
Phenylephrine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.91e-05	0.0016	CcSEcCtD
Phenylephrine—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.89e-05	0.0016	CcSEcCtD
Phenylephrine—Rash—Montelukast—chronic obstructive pulmonary disease	7.83e-05	0.00159	CcSEcCtD
Phenylephrine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.82e-05	0.00158	CcSEcCtD
Phenylephrine—Headache—Montelukast—chronic obstructive pulmonary disease	7.77e-05	0.00158	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.00156	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.00155	CcSEcCtD
Phenylephrine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.61e-05	0.00154	CcSEcCtD
Phenylephrine—Rash—Salbutamol—chronic obstructive pulmonary disease	7.54e-05	0.00153	CcSEcCtD
Phenylephrine—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.54e-05	0.00153	CcSEcCtD
Phenylephrine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.54e-05	0.00153	CcSEcCtD
Phenylephrine—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.53e-05	0.00153	CcSEcCtD
Phenylephrine—Nausea—Formoterol—chronic obstructive pulmonary disease	7.53e-05	0.00153	CcSEcCtD
Phenylephrine—Headache—Salbutamol—chronic obstructive pulmonary disease	7.5e-05	0.00152	CcSEcCtD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	7.42e-05	0.00597	CbGpPWpGaD
Phenylephrine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.39e-05	0.0015	CcSEcCtD
Phenylephrine—MAOA—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	7.39e-05	0.00594	CbGpPWpGaD
Phenylephrine—Nausea—Montelukast—chronic obstructive pulmonary disease	7.37e-05	0.00149	CcSEcCtD
Phenylephrine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.26e-05	0.00147	CcSEcCtD
Phenylephrine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	7.15e-05	0.00145	CcSEcCtD
Phenylephrine—ADRA1A—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	7.13e-05	0.00573	CbGpPWpGaD
Phenylephrine—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.11e-05	0.00144	CcSEcCtD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	7.06e-05	0.00567	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	6.94e-05	0.00558	CbGpPWpGaD
Phenylephrine—Shock—Prednisolone—chronic obstructive pulmonary disease	6.75e-05	0.00137	CcSEcCtD
Phenylephrine—MAOA—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.74e-05	0.00542	CbGpPWpGaD
Phenylephrine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.7e-05	0.00136	CcSEcCtD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	6.7e-05	0.00538	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.66e-05	0.00536	CbGpPWpGaD
Phenylephrine—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	6.65e-05	0.00535	CbGpPWpGaD
Phenylephrine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.63e-05	0.00134	CcSEcCtD
Phenylephrine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.00129	CcSEcCtD
Phenylephrine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.00128	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.00127	CcSEcCtD
Phenylephrine—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	6.24e-05	0.00501	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	6.17e-05	0.00496	CbGpPWpGaD
Phenylephrine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.16e-05	0.00125	CcSEcCtD
Phenylephrine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.15e-05	0.00125	CcSEcCtD
Phenylephrine—ADRA1B—AMPK Signaling—LEP—chronic obstructive pulmonary disease	5.94e-05	0.00477	CbGpPWpGaD
Phenylephrine—Pain—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.00119	CcSEcCtD
Phenylephrine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.00117	CcSEcCtD
Phenylephrine—MAOA—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	5.66e-05	0.00455	CbGpPWpGaD
Phenylephrine—Agitation—Prednisone—chronic obstructive pulmonary disease	5.61e-05	0.00114	CcSEcCtD
Phenylephrine—MAOA—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.6e-05	0.0045	CbGpPWpGaD
Phenylephrine—Syncope—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.00111	CcSEcCtD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	5.46e-05	0.00439	CbGpPWpGaD
Phenylephrine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.45e-05	0.0011	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.00109	CcSEcCtD
Phenylephrine—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	5.32e-05	0.00428	CbGpPWpGaD
Phenylephrine—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.00107	CcSEcCtD
Phenylephrine—ADRA1A—AMPK Signaling—LEP—chronic obstructive pulmonary disease	5.27e-05	0.00424	CbGpPWpGaD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.17e-05	0.00105	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.06e-05	0.00102	CcSEcCtD
Phenylephrine—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.91e-05	0.00394	CbGpPWpGaD
Phenylephrine—Shock—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000994	CcSEcCtD
Phenylephrine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000991	CcSEcCtD
Phenylephrine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000986	CcSEcCtD
Phenylephrine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.84e-05	0.000981	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000977	CcSEcCtD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	4.68e-05	0.00376	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.67e-05	0.00376	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	4.64e-05	0.00373	CbGpPWpGaD
Phenylephrine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.54e-05	0.000919	CcSEcCtD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	4.53e-05	0.00365	CbGpPWpGaD
Phenylephrine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000907	CcSEcCtD
Phenylephrine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	4.41e-05	0.00355	CbGpPWpGaD
Phenylephrine—Rash—Prednisolone—chronic obstructive pulmonary disease	4.33e-05	0.000877	CcSEcCtD
Phenylephrine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.32e-05	0.000876	CcSEcCtD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.00347	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.00347	CbGpPWpGaD
Phenylephrine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.31e-05	0.00347	CbGpPWpGaD
Phenylephrine—Headache—Prednisolone—chronic obstructive pulmonary disease	4.3e-05	0.000871	CcSEcCtD
Phenylephrine—MAOA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.29e-05	0.00345	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	4.25e-05	0.00342	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	4.2e-05	0.00338	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—CXCL8—chronic obstructive pulmonary disease	4.19e-05	0.00337	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.11e-05	0.0033	CbGpPWpGaD
Phenylephrine—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.08e-05	0.000826	CcSEcCtD
Phenylephrine—MAOA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.07e-05	0.00327	CbGpPWpGaD
Phenylephrine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	4.03e-05	0.00324	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	4.03e-05	0.00324	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	3.96e-05	0.00319	CbGpPWpGaD
Phenylephrine—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.96e-05	0.000803	CcSEcCtD
Phenylephrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	3.92e-05	0.00315	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	3.88e-05	0.00312	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—MMP9—chronic obstructive pulmonary disease	3.79e-05	0.00305	CbGpPWpGaD
Phenylephrine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000744	CcSEcCtD
Phenylephrine—ADRA1D—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	3.56e-05	0.00287	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	3.54e-05	0.00285	CbGpPWpGaD
Phenylephrine—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000715	CcSEcCtD
Phenylephrine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.0028	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	3.47e-05	0.00279	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	3.45e-05	0.00277	CbGpPWpGaD
Phenylephrine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.00277	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.43e-05	0.00276	CbGpPWpGaD
Phenylephrine—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.3e-05	0.000668	CcSEcCtD
Phenylephrine—ADRA1B—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	3.29e-05	0.00264	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APIP—chronic obstructive pulmonary disease	3.27e-05	0.00263	CbGpPWpGaD
Phenylephrine—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.17e-05	0.000642	CcSEcCtD
Phenylephrine—Rash—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000637	CcSEcCtD
Phenylephrine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000636	CcSEcCtD
Phenylephrine—Headache—Prednisone—chronic obstructive pulmonary disease	3.12e-05	0.000633	CcSEcCtD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	3.1e-05	0.00249	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—EGFR—chronic obstructive pulmonary disease	3.06e-05	0.00246	CbGpPWpGaD
Phenylephrine—Nausea—Prednisone—chronic obstructive pulmonary disease	2.96e-05	0.0006	CcSEcCtD
Phenylephrine—ADRA1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.96e-05	0.00238	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	2.95e-05	0.00237	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	2.94e-05	0.00236	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.94e-05	0.00236	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	2.92e-05	0.00235	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.92e-05	0.00235	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	2.88e-05	0.00231	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.84e-05	0.00229	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.83e-05	0.00227	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	2.71e-05	0.00218	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.68e-05	0.00215	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.63e-05	0.00211	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.62e-05	0.00211	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	2.61e-05	0.0021	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	2.57e-05	0.00207	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	2.56e-05	0.00205	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	2.54e-05	0.00204	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.53e-05	0.00203	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.5e-05	0.00201	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.49e-05	0.002	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.46e-05	0.00198	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.44e-05	0.00196	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.43e-05	0.00196	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.42e-05	0.00195	CbGpPWpGaD
Phenylephrine—ADRA1B—AMPK Signaling—TP53—chronic obstructive pulmonary disease	2.42e-05	0.00195	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	2.39e-05	0.00192	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.3e-05	0.00185	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	2.29e-05	0.00184	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.27e-05	0.00182	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.24e-05	0.0018	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.22e-05	0.00179	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.18e-05	0.00175	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.17e-05	0.00174	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.16e-05	0.00174	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.15e-05	0.00173	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—TP53—chronic obstructive pulmonary disease	2.15e-05	0.00173	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	2.11e-05	0.0017	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.07e-05	0.00167	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.06e-05	0.00166	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.02e-05	0.00162	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.01e-05	0.00162	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2e-05	0.00161	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.98e-05	0.00159	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.96e-05	0.00158	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.93e-05	0.00156	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.91e-05	0.00153	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.88e-05	0.00151	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.86e-05	0.00149	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	1.85e-05	0.00149	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.84e-05	0.00148	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.83e-05	0.00147	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	1.82e-05	0.00146	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	1.82e-05	0.00146	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.77e-05	0.00142	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.77e-05	0.00142	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.75e-05	0.00141	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.75e-05	0.0014	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	1.73e-05	0.00139	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.73e-05	0.00139	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.72e-05	0.00139	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.7e-05	0.00137	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.69e-05	0.00136	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.67e-05	0.00135	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.67e-05	0.00134	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.66e-05	0.00133	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.65e-05	0.00133	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.58e-05	0.00127	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.56e-05	0.00126	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.52e-05	0.00122	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.5e-05	0.00121	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.49e-05	0.00119	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.00119	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.47e-05	0.00118	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.47e-05	0.00118	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.45e-05	0.00117	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.43e-05	0.00115	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.00114	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.4e-05	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.35e-05	0.00108	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.34e-05	0.00108	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.3e-05	0.00105	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.29e-05	0.00104	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.26e-05	0.00102	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.21e-05	0.000971	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.18e-05	0.000946	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.16e-05	0.000934	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000927	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.000923	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000916	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.13e-05	0.000908	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.11e-05	0.000895	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.08e-05	0.000869	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000868	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000865	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000843	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.000841	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000836	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.03e-05	0.00083	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000824	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.88e-06	0.000795	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.88e-06	0.000794	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.58e-06	0.00077	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.52e-06	0.000766	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	9.37e-06	0.000754	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.32e-06	0.000749	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.97e-06	0.000721	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.97e-06	0.000721	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.96e-06	0.000721	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	8.93e-06	0.000718	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	8.61e-06	0.000692	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.51e-06	0.000684	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.46e-06	0.00068	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.32e-06	0.000669	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	8.2e-06	0.000659	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8e-06	0.000643	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.99e-06	0.000642	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.97e-06	0.00064	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.96e-06	0.00064	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	7.93e-06	0.000638	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.9e-06	0.000635	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.88e-06	0.000633	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	7.78e-06	0.000626	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.56e-06	0.000608	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.45e-06	0.000599	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.35e-06	0.000591	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.34e-06	0.00059	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.28e-06	0.000586	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.23e-06	0.000582	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.96e-06	0.00056	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.78e-06	0.000545	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.61e-06	0.000532	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.56e-06	0.000527	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.1e-06	0.000491	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.1e-06	0.00049	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.06e-06	0.000487	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.82e-06	0.000468	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.76e-06	0.000463	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.63e-06	0.000452	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.54e-06	0.000446	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.51e-06	0.000443	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.42e-06	0.000435	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.3e-06	0.000426	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.07e-06	0.000407	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.03e-06	0.000404	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5e-06	0.000402	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.93e-06	0.000396	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	4.73e-06	0.00038	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.6e-06	0.00037	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.57e-06	0.000367	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	4.53e-06	0.000364	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.5e-06	0.000362	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.47e-06	0.000359	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.4e-06	0.000354	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.25e-06	0.000342	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.2e-06	0.000338	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.09e-06	0.000329	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.09e-06	0.000328	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.06e-06	0.000326	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.05e-06	0.000326	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.92e-06	0.000315	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.91e-06	0.000314	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.87e-06	0.000311	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.83e-06	0.000308	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.69e-06	0.000297	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.63e-06	0.000292	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.36e-06	0.00027	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.27e-06	0.000263	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.21e-06	0.000258	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.11e-06	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.06e-06	0.000246	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.99e-06	0.00024	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.96e-06	0.000238	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.95e-06	0.000237	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.91e-06	0.000234	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.85e-06	0.000229	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.72e-06	0.000219	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.72e-06	0.000218	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.71e-06	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.66e-06	0.000214	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.58e-06	0.000208	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.57e-06	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.46e-06	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.44e-06	0.000196	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.41e-06	0.000194	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.39e-06	0.000192	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.3e-06	0.000185	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.21e-06	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.18e-06	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.03e-06	0.000163	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.01e-06	0.000162	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.99e-06	0.00016	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.96e-06	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.84e-06	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.8e-06	0.000145	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.76e-06	0.000142	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.74e-06	0.00014	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.67e-06	0.000134	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.67e-06	0.000134	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.53e-06	0.000123	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.48e-06	0.000119	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.36e-06	0.000109	CbGpPWpGaD
